Navigation Links
Acclaimed Author Lionel Shriver Supports Mesothelioma Awareness Day
Date:8/25/2014

Alexandria, VA (PRWEB) August 25, 2014

The Mesothelioma Applied Research Foundation (Meso Foundation) released today a video of award-winning author, Lionel Shriver, in which Ms. Shriver urges viewers to observe September 26th as Mesothelioma Awareness Day. The video can be watched on the Meso Foundation’s YouTube channel.

“Several years ago, one of my closest friends, was diagnosed with mesothelioma,” says Ms. Shriver in the video. “Her experience of living with the disease, and ultimately dying from it, moved me to write my tenth novel, ‘So Much for That.’”

“So Much for That” is a novel that tackles the complicated topic of healthcare in the United States, through the experience of a mesothelioma patient and her family.

In the video, viewers are urged to visit the organization’s website, curemeso.org, to learn more about Mesothelioma Awareness Day.

Ms. Shriver is best known as the author of the award-winning novel “We Need to Talk About Kevin,” and “Big Brother.”

Mesothelioma Awareness Day is a grassroots movement established in 2004 by volunteers of the Meso Foundation with the goal of bringing more attention and funding to this historically-neglected cancer.

“On behalf of the mesothelioma community, I am infinitely grateful to Ms. Shriver for her help in raising awareness,” said nurse practitioner and executive director of the Mesothelioma Applied Research Foundation, Mary Hesdorffer.

“More awareness of this disease and the consequent increased funding for research, education, support, and advocacy is exactly what is needed to help us save lives,” added Ms. Hesdorffer.

Mesothelioma is a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos. With the life expectancy of less than one year after diagnosis, medical experts consider it one of the most aggressive and deadly of all cancers. An estimated one-third of those who develop mesothelioma were exposed while serving in the Navy or working in shipyards. Currently, few treatment options exist. There is no cure.

ABOUT THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION
The Meso Foundation is the only 501(c)(3) nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation actively seeks philanthropic support to fund mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer-reviewed scientific research to develop life-saving treatments for this extremely aggressive cancer. To date, the Foundation has awarded over $8.7 million to research. More information is available at http://www.curemeso.org.

###

Read the full story at http://www.prweb.com/releases/2014/08/prweb12118242.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. CVS Caremark Adds New, Natural Acclaimed Hair Care Line to its Beauty Roster
2. Oregon's Most Acclaimed Medical Marijuana "Canna Kitchen" Whips Up Smokeless Remedies for Albany OMMP Patients
3. Acclaimed 9/11 Photographer Gary Suson to Conduct 'Final' Press Interviews
4. Edward J. Bergman, New Jersey's Highly Acclaimed Mediator, Joins Leading Website Mediation.com
5. Patient Advocate for CancerConnect.com and Acclaimed Writer, Jamie Reno, Delivers Devastating News of Lifesaving Cancer Drug's Discontinuation
6. Acclaimed Fitness Business Consultant Shows Personal Trainers How to Grow a Fitness Business with Search Engine Optimization
7. Nationally Acclaimed Addictions Specialist Dan Cronin Joins Journey Malibu - The Leader in One-on-One Treatment
8. Kick-Start Your Weight Loss Today and Get a Massive 15-Percent Off the Acclaimed Pure Garcinia Cambogia Extract; Only While Stocks Last
9. Internationally Acclaimed Breast Augmentation Expert Announces the Launch of His New Website
10. Living Well Medical, a Top NYC Medical Facility, Welcomes Acclaimed Orthopedist Dr. Randall Victor Ehrlich, M.D.
11. Acclaimed Texas Surgeon Offers Hope through Expertise in Erb’s Palsy Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... United Benefit Advisors ... the latest addition to its growing list of Partner Firms. S.S. Nesbitt ... from Orlando to Huntsville and in between. , Harnessing the experience and insights ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... time Emmy award winner and inspirational speaker Jan Fox will serve as keynote ... Speaking Boldly will provide participants with tools to more effectively communicate with their ...
(Date:2/10/2016)... Beach, Florida (PRWEB) , ... February 10, 2016 ... ... Country Club) announced that it has been awarded the prestigious Distinguished Emerald Club ... World award program conducted by BoardRoom magazine, one of the most respected trade ...
(Date:2/10/2016)... CA (PRWEB) , ... February 10, 2016 , ... Workrite ... and most versatile series of monitor mounts ever. , “Our goal was to ... and easy to install system that we have ever created.” said Darren Hulsey, Product ...
(Date:2/10/2016)... ... February 09, 2016 , ... A new leadership team for ... FHU President Joe Wiley made the announcement Monday night, Feb. 8, prior to the ... graduate of FHU and the creator of GO! Camp, has been named director. Gayle ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... New York , February 10, 2016 ... Growth, Trends and Forecast 2015 - 2023 ", reveals that ... rather slow growth from 2015 to 2023 owing to patent ... a meager CAGR of 1.30% during the forecast period, the ... to US$38.9 bn in 2023. --> Antibacterial Drugs ...
(Date:2/10/2016)... 10, 2016 Intouch Solutions, a leading marketing ... industry-wide trend regarding the evolution of digital sales ... efficiently deliver compelling sales presentations via tablets. After ... in 2015, Intouch uncovered that while most pharmaceutical ... DSAs, many are not using them effectively during ...
(Date:2/10/2016)... , Feb. 9, 2016 ... Drug Administration (FDA) met with its Arthritis ... proposed biosimilar of Johnson & Johnson,s Remicade ... be approved in the U.S. The Biologics ... physician groups - Alliance for Patient Access, ...
Breaking Medicine Technology: